期刊文献+

不同能量氩离子激光照射防止翼状胬肉术后复发的研究 被引量:1

Different-energy Argon Laser in Prevention of Postoperative Recurrence of Pterygium:a Clinical Research
下载PDF
导出
摘要 目的探讨不同能量氩离子激光防止翼状胬肉术后复发的效果。方法将116例116只眼原发性翼状胬肉术后1周手术区结膜或角膜缘出现新生血管胚芽的患者分为3组:(1)低能量氩离子激光光凝组(A组)56例,功率0.1~0.15W;(2)常规能量氩离子激光光凝组(B组)30例,功率0.2~0.3W;(3)对照组(C组)30例,不行光凝。结果随访1年,A、B、C组胬肉术后复发率分别为7.1%、10.0%、33.3%。激光治疗后A组患者结膜充血、结膜灼伤、结膜充血的发生率均低于B组(P<0.05)。结论低能量氩离子激光照射封闭胬肉术后1周新生血管胚芽,为防止翼状胬肉术后复发的一种有效方法,激光治疗后胬肉早期新生血管胚芽、结膜灼伤、结膜出血等局部反应较少。 Objective To explore the effect of diffrent-energy argon laser on preventing the postoperative recurrence of pterygium. Methods A total of 116 cases( 116 eyes) with new vessels appearing in surgery site of cornea and/or conjunctivae one week after undergoing pterygium excision were divided into 3 groups: group A(56 cases,56 eyes) received low-energy argon laser photaeoagulation, power: 0. 1-0. 15 W; group B (30 cases, 30 eyes) received normal-energy argon laser photocoagulation, power 0. 2-0. 3 W;group C (30 cases,30 eyes) didnt receive any argon laser photocoagulation. Results After one year follow-up, the rate of postoperative recurrence of. three groups was 7. 1%, 10.0% and 33. 3%, respectively. As compared with group C, the rate of postoperative recurrence of groups A and B was significantly decreased ( P 〈 0. 05 and 〈 0. 01, respectively). As compared with group B, the rate of postoperative recurrence of group A was not significantly changed (P 〉 0. 05) ; but the complications of conjunctive burn and hemorrhage in group A were significantly decreased( P 〈 0.05). Conclusions Using argon laser to coagulate new vessels can reduce the postoperative recurrence rate the of ptcrygium. And low-energy argon laser can reduce the complications of photocoagulation, it's an effective and safe treatment in preventing the postoperative recurrence of pterygium.
出处 《中国激光医学杂志》 CAS CSCD 2009年第5期287-289,共3页 Chinese Journal of Laser Medicine & Surgery
基金 广西壮族自治区科技厅科技攻关项目(桂科攻0015031)
关键词 激光 翼状胬肉 术后复发 Laser Pterygium Postoperative recurrence
  • 相关文献

参考文献3

二级参考文献49

  • 1王雨生.翼状胬肉的治疗及其并发症[J].国外医学:眼科学分册,1994,18(2):116-121.
  • 2Al-Bdour M, Al-Latayfeh MM. Risk factors for pterygium in an adult Jordanian population. Acta Ophthalmol Scand, 2004, 82: 64-67.
  • 3Gazzard G, Saw S-M, Farook M, et al. Pterygium in Indonesia:prevalence, severity and risk factors. Br J Ophthalmol , 2002, 86:1341-1346.
  • 4Gallagher MJ, Giannoudis A, Herrington CS, et al. Human papillomavirus in pterygium. Br J Ophthalmol ,2001, 85:782-784.
  • 5Piras F, Moore PS, Ugalde J, et al. Detection of human papillomavirus DNA in pterygia from different geographical regions. Br J Ophthalmol, 2003, 87:864-866.
  • 6Chen KH, Hsu WM, Cheng CC, et al. Lack of human papillomavirus in pterygium of Chinese patients from Taiwan. Br J Ophthalmol,2003, 87:1064-1066.
  • 7Islam SI. Wagoner MD. Pterygium in young members of one family. Cornea,2001, 20:708-710.
  • 8Coroneo MT, Girolamo ND, Wakefield D. The pathogenesis of pterygia. Curr Opin Ophthalmol, 1999, 10:282-288.
  • 9Girolamo ND, Tedla N, Kumar RK, et al. Culture and characterization of epithelial cells from human pterygia. Br J Ophthalmol,1999,83:1077-1082.
  • 10Shimmura S, Isbioka M, Hanada K, et al. Telomerase activity and p53 expression in pterygia. Invest Ophthalmol Vis Sci, 2000,41:1364-1369.

共引文献488

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部